Xoma(美國(guó))

Xoma

美國(guó)Xomawww.xoma.com美國(guó)Xoma成立于1981年，是一家生物制藥公司發(fā)現(xiàn)，開(kāi)發(fā)和制造用于治療炎癥，自身免疫，傳染性疾病和腫瘤治療性抗體的重點(diǎn)。XOMALtd.(XOMA),incorporatedin1981,isabiopharmaceuticalcompanyfocusedonthediscovery,developmentandmanufactureoftherapeutic antibodiesdesignedtotreatinflammatory,autoimmune,infectiousandoncologicaldiseases.TheCompany’sproductdevelopmentpipelineincludesXOMA052,ananti-interleukin-1beta(IL-1beta)antibody,XOMA3AB,abiodefenseanti-botulismantibodycandidate,andpreclinicalantibodydiscoveryprogramsinseveralindications.XOMAhaveanintegratedproductdevelopmentplatform,extendingfrompreclinicalsciencetodevelopmentandmanufacturing.TheCompany’stechnologieshavecontributedtothesuccessofmarketedantibodyproducts,includingLUCENTIS(ranibizumabinjection)forwetage-relatedmaculardegenerationandCIMZIA(certolizumabpegol)forrheumatoidarthritisa